VERAXA Biotech and Voyager file F-4 registration for merger
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
July 17, 2025 8:55 AM EDTZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (VERAXA or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., Â a Cayman Islands exempted company and special purpose acquisition company targeting the healthcare sector (NASDAQ:VACH, Voyager or... More
